Rossella Medori

Rossella Medori brings more than 20 years of neuroscience expertise to AFFiRiS and has an extensive track record in successful CNS drug development. Before joining AFFiRiS, she led Prexton Therapeutics to a successful early exit, had key leadership roles at Biogen (including Vice President of Translational Neurology and Vice President of Late Clinical Development) and served in European and Global Medical leadership roles at Janssen-Cilag, BMS and Lilly. Rossella practiced as a Clinical Neurologist in Italy, the United States and Germany and held various academic positions at Case Western Reserve University, Washington University and Columbia University. The identification of the DNA mutations associated with different forms of muscular dystrophy and the description of a new prion disease called Fatal Familial Insomnia are among her most important scientific contributions.